The lncRNA ANRIL and SChLAP1 are overexpressed in prostate cancers and antagonize the tumour-suppressive activity of INK4a/b and SWI/SNF complex, respectively33, 34. This evidence concerns the gene CDKN2B-AS1 and prostate carcinoma.